CURRENT GOOD MANUFACTURING GUIDELINES FOR MEDICINAL PRODUCT
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2016, Vol 6, Issue 2
Abstract
The holder of a manufacturing authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation and do not place patients at risk due to inadequate safety, quality or efficacy. The attainment of this quality objective is the responsibility of senior management and requires the participation and commitment by staff in many different departments and at all levels within the company, by the company’s suppliers and by the distributors. To achieve the quality objective reliably there must be a comprehensively designed and correctly implemented system of Quality Assurance Incorporating Good Manufacturing Practice, and thus Quality Control and Quality Risk Management. It should be fully documented and its effectiveness monitored. All parts of the Quality Assurance systems should be adequately resourced with competent personnel, and suitable and sufficient premises, equipment and facilities. There are additional legal responsibilities for the holder of the manufacturing authorisation and for the authorised person Keywords: Good Manufacturing Practice, Quality control, Quality assurance, authorised
FORMULATION AND DEVELOPMENT OF KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION
An acetic acid derivative ketorolac tromethmine has found its applicability in both gram positive and gram negative bacterial ocular infection and used commonly associated with multiple doses. Ophthalmic medication store...
A comprehensive review on pharmaceutical mini tablets
Mini-tablets represent a new trend in solid dosage form design, with the main goal of overcoming some therapeutic obstacles. Mini tablets are multiple unit dosage forms and are advantageous than pellets or any other oral...
Enhanced dissolution and solubility of Epalrestat with β-Cyclodextrin ternary complex using Arginine
The objective of present is work to achieve improvement in solubility and dissolution using Epalrestat with β-cyclodextrin ternary complex with addition of L-arginine. Kneading method with and without incorporation of L-...
A NOVEL QSAR MODEL FOR EVALUATING AND PREDICTING THE INHIBITION ACTIVITY OF H1-RECEPTOR ANTAGONISTS: A SERIES OF THIENOPYRIMIDINE DERIVATIVES
A Quantitative Structure Activity Relationship (QSAR) study has been established using combination of most influencing physiochemical parameters viz. thermodynamic, electronic, geometric & quantum mechanical descript...
TASTE MASKING EVALUATION AND FORMULATION OF DICYCLOMINE HYDROCHLORIDE SUSPENSION USING ION EXCHANGE RESINS
There are number of drugs that are bitter and unpleasant in taste and taking orally very difficult for children and some adults. Nonâ€compliance can lead to many problems in diseased condition. There are lots of taste...